DEPARTMENT OF PSYCHIATRY Donor News and Impact Report
2023
A LETTER FROM THE CHAIR Dear Friends, I am delighted to share the U-M Department of Psychiatry’s Donor News and Impact Report for 2023. Despite emerging from a pandemic, our highly ranked department continues to excel in treatment, research, and training. Our faculty are obtaining prestigious federal and industry grants and impacting the field through publishing and innovations in care delivery — like seeing more patients than ever via telehealth. Donors make this possible, and we are grateful. As part of a public university, we are committed to serving our community by promoting the importance of mental health and ensuring those struggling with mental illness get the care they need. We are thrilled that the National Suicide & Crisis Lifeline — 988 — has been implemented in the state of Michigan when so many are dealing with untreated mental health challenges. Combined with the shortage of mental health professionals, our communities are in crisis — which we at Michigan Medicine are striving to address. Chief among our priorities is helping the rising number of kids dealing with depression, anxiety, and more. It’s why our innovative researchers, including those in the Addiction Center, are developing new strategies and preventives. Access to care remains a barrier, but we are reaching more kids more quickly by partnering with schools, primary care offices, and emergency services, while increasing capacity for kids at U-M by establishing a child and adolescent partial hospital program in Washtenaw County. We appreciate all you do for the Department of Psychiatry through your involvement, compassion, and visionary generosity. As you read the following pages, I hope you will share our pride in some of what your support helps us do. On behalf of our faculty, staff, learners, and patients, thank you.
Sincerely,
Sincerely,
GregoryW. W. Dalack, Dalack,MD M.D. Gregory Chair, Department Associate Professorof Psychiatry Daniel E. Offutt IIIAssociate ProfessorChair of Psychiatry Interim Chair and for Education and Academic Affairs gdalack@med.umich.edu
Thanoku! y
CONTENTS Pioneering Approaches Increase Access to Mental Health Care 2-3 Leading the Way to Innovations in Child and Adolescent Mental Health 4-7 Research Programs 8-9 Faculty Support 10-11
“My late husband Jim and I have been proud supporters of mental health research at Michigan Medicine. It makes such a difference for so many families faced with mental health challenges — including our own. Remembering the University of Michigan in our estate plans is important as it will allow this vital work to continue in perpetuity and create a meaningful legacy.” -Betsy Cooke
Visit our website to learn more: umpsych.org
Thank you for supporting the University of Michigan Health Department of Psychiatry. We are committed to conducting leading-edge research. Much of that work focuses on developing, testing, and refining the best possible treatment interventions to meet people where they are, and giving people hope for a happier, healthier future. Thank you for your generous support.
PIONEERING APPROACHES INCREASE ACCESS TO MENTAL HEALTH CARE
According to the National Alliance on Mental Illness (NAMI), more than one in five U.S. adults and one in six youth experience mental illness each year. Unfortunately, those who seek help often face barriers such as stigma, lack of insurance, and logistical issues that prevent them from accessing treatment. At University of Michigan Health, we are working to address barriers to mental health treatment so more people can access the care they need. The use of telehealth, a form of remotely-delivered health care, experienced a significant surge during the COVID-19 pandemic. Telehealth, or virtual appointments, can make health care much more accessible by reducing or eliminating problems like scheduling difficulties, lack of transportation, and difficulty finding childcare. “Currently, one in six health care visits occur through telehealth,” says Chad Ellimoottil, M.D., assistant professor of urology and medical director of virtual care for the University of Michigan Medical Group. The Department of Psychiatry provided 61,100 telehealth visits to our patients in fiscal year 2023. Philanthropic support of our telehealth program provides training for residents and medical students so we can reach more people through telehealth and support research projects that will help us better understand how telehealth impacts patient outcomes. We are using another health care innovation, collaborative care, to bring mental health services to people outside of traditional mental health care settings. In collaborative care, expert providers support primary care providers in delivering more specialized services than they would normally provide on their own. The expert providers also help 2
guide patients to higher levels of care when needed. Collaborative care improves results and cuts costs while allowing people to receive the highest quality of care from their own primary care provider. One collaborative care model that has produced outstanding results is the Kalamazoo Collaborative Care Program (KCCP). KCCP is a donor-supported initiative that began when concerned members of the Kalamazoo community joined with faculty at University of Michigan Health to find ways to improve awareness, prevention, and treatment of depression and suicide risk in their community. U-M psychiatry experts partnered with Bronson Health to identify and assess community mental health needs and then worked with Bronson’s primary care providers to increase their capacity to address depression and suicide risk. KCCP has resulted in an improved standard of mental health care for the Kalamazoo community. Its success, and the broader implementation of collaborative care throughout Michigan Medicine, caught the attention of Blue Cross Blue Shield of Michigan, which is now partnering with U-M to expand the model across the state of Michigan through a program called the Michigan Collaborative Care Program.
Launched with Philanthropy, Program Meets People Where They Are The Michigan Clinical Consultation & Care Program (MC3) is a psychiatry access program that helps people access mental health services through primary care. MC3 addresses the urgent mental health needs of pregnant and postpartum people in addition to children and adolescents all over the state of Michigan. A U-M team of pediatric and perinatal psychiatrists provides free, same-day psychiatry consultations to primary care providers in Michigan who work with pediatric and perinatal patients, helping them grow their skills so they can more confidently care for their patients. In addition, Maria Muzik, M.D., M.S., professor of psychiatry, obstetrics and gynecology, and co-director of Zero to Thrive, is leading an innovative six-county pilot program through MC3 that provides same-day access to mental health screening and oneon-one psychotherapy to pregnant and postpartum patients using telehealth. MC3 was originally funded with donor support, and since the program received state funding to provide direct care to perinatal patients in fall 2021, MC3 has provided 3,330 psychotherapy sessions and care coordination to 360 pregnant and postpartum patients. This includes 2,347 sessions and 983 instances of care coordination.
Maria Muzik, M.D., M.S.
People who need mental health services often have to wait several weeks or more, but MC3 allows children, adolescents and perinatal patients to begin to receive care immediately, any day of the week, which is an important innovation.
3
PROGRAM UPDATES
LEADING THE WAY TO INNOVATIONS IN CHILD AND ADOLESCENT MENTAL HEALTH
Nasuh Malas, M.D., MPH
We are committed to advancing mental health care for children and adolescents. As more and more young people face mental health issues, donor support helps us innovate and expand the services we provide to better meet their needs. “Donor support has a tremendous impact on the access to and delivery of care to youth and families, the patient and family experience, promoting innovation and cutting-edge treatments, continuing to foster excellent training, and development for our faculty, nurses and staff,” says Nasuh Malas, M.D., MPH, clinical associate professor of psychiatry and pediatrics and the newly appointed director of Child and Adolescent Psychiatry. “Donor funding elevates and enhances our clinical, education, and research activities,” he says, “while opening doors for pilot projects, quality improvement efforts, new initiatives and programs, as well as innovations that allow our Child Psychiatry Division and department to better support our patients, families, and communities.” Dr. Malas and his team have an exciting vision for transformational change, allowing Michigan Medicine to expand services to this patient population. The expanded services include a child and adolescent partial hospitalization program for youth with mood disorders, anxiety disorders, or suicidal thoughts and behaviors that will open in 2025 and will be housed in Michigan Medicine’s new Ypsilanti Health Center. Philanthropy plays a critical role in helping us reach more kids facing mental health challenges. Thank you for ensuring that we can continue to evolve and offer the most effective and compassionate mental health services to our young patients and their families.
4
Partial hospitalization program to serve children and adolescents who face serious mental health challenges
Joanna Quigley, M.D.
Thanks to philanthropic support, we have been able to take the first steps toward establishing a partial hospitalization program (PHP) for children and adolescents who are facing serious mental health challenges. We have conducted an in-depth analysis and assessment to guide us through the development of a PHP that will bridge important gaps by serving children and adolescents who cannot be safely cared for in traditional outpatient programs while preventing their illness from progressing to the point that they require emergency or inpatient care. The PHP will be an important resource for the community by helping to relieve some of the unmet need for psychiatric services among this population.
We have received a grant from the State of Michigan Department of Health and Human Services to help us build this service, and a site in the new Ypsilanti Health Center has been secured. We anticipate that the PHP will begin to serve young people in 2025, and donor support will continue to be central to education, research, and patient care. Joanna Quigley, M.D., clinical associate professor of psychiatry and pediatrics and the associate medical director of Child & Adolescent Ambulatory Psychiatry, has been leading the planning for the PHP on behalf of Psychiatry. “We’re very excited to move forward with this new clinical program – it is a critical step in improving access to care for the kids we serve,” says Dr. Quigley. “This is just one example of how the caring donors in our community have helped, and will continue to help us in our efforts to meet the needs of children, adolescents, and their families with the right type of care, in the right type of environment to meet their needs.”
Supporting families from pregnancy through early childhood During the 1970s, University of Michigan researchers pioneered what is now the internationally-recognized field of infant mental health. Today, this trailblazing work continues through the Zero to Thrive program in the University of Michigan Health Department of Psychiatry. Founded in 2010 by Katherine L. Rosenblum, Ph.D., and Maria Muzik, M.D., Zero to Thrive is dedicated to the well-being and resilience of families, with a focus on families exposed to adversity. This important work is supported by donor generosity, which makes life-changing research, training, and education possible. With donor support, Zero to Thrive’s multidisciplinary team of experts has developed evidence-based programs that are proven to strengthen relationships between caregivers and children and shared them with families, learners, and community-based agencies across the nation. To date, more than 500 providers in nine states have been trained to implement these “Strong Roots™” programs in their own agencies and communities, ultimately reaching thousands of families. “We focus on research and creating programs to support families, specifically addressing the effects of inequities, trauma, and adversity,” says Diana Saum, Strong Roots project coordinator. Over a decade of research shows that Strong Roots participants experience improved confidence and comfort in parenting as well as a reduction in stress, depression, PTSD, and social isolation as a result of the interventions they receive. Our donors also allow us to reach more children and families in need through their generous support of Zero to Thrive’s scholarship fund, which helps to cover the cost of Strong Roots training for professionals who need this assistance. Once trained, facilitators can host groups that serve up to 25-30 parent-child pairs per session, so this investment gives back exponentially. 5
Donor generosity brings improvements to childrens’ mental health programs Thanks to the philanthropic support of the Joseph and Karen Krantz Family Charitable Foundation, we have made some wonderful improvements in our children’s psychiatry programs. Studies show that interactions with trained therapy animals benefit people’s mental and physical health. With the Krantz Family Foundation’s support, we have added a therapy dog named Barney to the Nyman Family Unit for Child and Adolescent Mental Health and Wellness at C.S. Mott Children’s Hospital. The Krantz Family Foundation also funded a therapy dog named McCoy for the adult psychiatric inpatient unit. Barney and McCoy are part of Michigan Medicine’s Paws4Patients program, which is generously supported by donors and now has six dogs that support patients throughout Michigan Medicine. The visionary generosity of the Krantz Family Foundation also enabled us to add large, colorful sensory floor decals and five child therapy toy kits in the Child Psychotherapy Clinic. The decals include vibrant flowers, leaves, and blades of grass that decorate the floors and make the space more inviting for children and their families during play therapy. The toy kits contain diverse family figurines, houses, and playing pieces that help children to tell their stories through play. They can also use the kits to depict and express challenging realities and feelings. Play is very important for children because it helps them articulate real experiences, fantasy, and symbolism.
Three of Michigan Medicine’s six therapy dogs with their handlers. These furry friends are part of Michigan Medicine’s Paws4Patients program, which is supported by donor generosity.
6
Two new endowed funds will support early-career research and priority projects in child and adolescent psychiatry The Kathy Ashton-Miller Fund in Child and Adolescent Psychiatry was established by James Ashton-Miller, Ph.D., the Albert Schultz Collegiate Research Professor and Distinguished Research Scientist in the University of Michigan Departments of Mechanical Engineering and Biomedical Engineering. Dr. Ashton-Miller and his family created the fund in 2021 to honor the memory of his wife, Kathy Ashton-Miller, who was a champion for children and first worked as a K-6 teacher for 15 years. She retired as lecturer emeritus after educating more than 1,000 Eastern Michigan University student teachers over more than three decades in southeast Michigan schools. She was passionate about helping children overcome the challenges they face and was especially concerned about mental health. In 2006, Kathy founded a volunteer group to support the U-M Depression Center. Under her leadership, the group held community events to raise funds for children’s mental health programs.
Kathy Ashton-Miller
The Kathy Ashton-Miller Fund was made possible through the generosity of over 150 donors from all over the world. It will develop the next generation of experts in child and adolescent mental health by supporting early-career faculty members whose research is focused on improving the lives of children and adolescents who are living with depression and related illnesses. Sisters Julia Hoff Haughey and Allison Hoff grew up in Ann Arbor and were familiar with the critical role that philanthropy plays in academic medicine. Their late father, Julian Hoff, M.D., was a professor and chair of the University of Michigan Medical School Department of Neurosurgery. Allison and Julia’s father and their mother, Diane, instilled a philanthropic spirit in their children that inspired them to give back to causes at Michigan Medicine that are important to them. In 2022, the Hoff sisters established the Allison Hoff and Julia Hoff Haughey Fund for Research and Innovation in Adolescent Mental Health. Funds from this endowment will be used to support the most promising and innovative work in adolescent mental health and will be awarded annually at the discretion of the department chair and the director of child and adolescent psychiatry.
Julia Hoff Haughey and Allison Hoff 7
RESEARCH PROGRAMS
Soo-Eun Chang, Ph.D.
The mobile lab
Pursuing Novel Research to Uncover the Mechanisms Behind Stuttering Stuttering is a complex neurodevelopmental disorder that affects up to 8% of preschool-aged children and continues as a chronic disorder in 1% of the general population. Its neurological origins remain a mystery, and a lack of research and knowledge about stuttering has hindered the development of effective treatments that help people recover from its symptoms. Soo-Eun Chang, Ph.D., holds the Rosa Casco Solano-Lopez Professorship in Child and Adolescent Psychiatry, which was established with a gift from alumnus Carlos Solano-Lopez. Dr. Chang is a speechlanguage pathologist and the unstoppable force behind what has become the Stuttering Research Program within the Speech Neurophysiology Lab at the University of Michigan. The lab is internationallyrenowned for groundbreaking studies on the neural bases of stuttering. Dr. Chang’s work has attracted leading speech experts to the lab as well as transformative gifts from multiple donors to support research on neuroscience-guided treatment approaches. Philanthropic support has sparked groundbreaking stuttering research projects that have received international attention and grant funding. One study identified differences in brain white matter between children who stutter and those who don’t and provided the first look at neuroanatomical deficits associated with childhood stuttering. Another important project revealed differences in rhythm perception among children who stutter. A longitudinal study that compared children aged 6 to 11 years — those who stutter and those who don’t — in terms of their auditory rhythm discrimination abilities found that the children who stutter exhibited lower rhythm discrimination compared to children who
8
don’t, providing the first-ever evidence of impaired intrinsic timing ability. Dr. Chang is continuing this study to focus on very young children who stutter. The lab continues to pursue innovative research projects that have attracted grant funding and national attention, none of which would have been possible without donor support. This type of generosity funds the initial work that must take place in order to demonstrate the potential of a new idea and qualify a project for larger grants from federal and other organizations. Donor generosity is central to our work. After years of conducting research in the lab, Dr. Chang and her team were eager to bring their work to research participants so they would not have to be burdened with the commute to Ann Arbor. Thanks to the generous support of our donors, the Mobile Research Lab was born. The vehicle, a van outfitted with state-of-the-art lab equipment and decorated with a wolverine mascot, allows the team to meet patients at their homes and in their communities when researchers need to collect behavioral and neurophysiological data. Speech on Wheels is yet another new initiative. Led by a U-M student group of medical students mentored by Dr. Chang, Speech on Wheels was established through donor generosity and supports the various community outreach events where the Mobile Research Lab makes an appearance, offering free speech and language screenings for children ages 3-12. These efforts create important opportunities by giving families an opportunity to speak with a speech pathologist whom they might not otherwise have a chance to meet, while also recruiting study participants. These events also encourage medical students pursuing community outreach in their future careers.
Addiction Center Research Catalyst Innovation Awards The U-M Addiction Center Research Catalyst Innovation Awards is a donor-funded grant program focused on providing pilot funds for innovative ideas in addiction research. The awards help to develop the next generation of experts by prioritizing early-career investigators. The list of recipient projects represents the breadth of research among addiction faculty — including techniques for modulating substance use to prevent substance use disorders, quantifying the cognitive effects of daily alcohol consumption, identifying how brain processes differ for those with addiction, and even the impact of public policy on substance use. Frederic Blow, Ph.D., director of U-M Addiction Center, expressed the importance of making these awards: “The U-M Addiction Center Research Catalyst Innovation Awards are a great way to drive progress and enhance the well-being of individuals grappling with substance use disorders. These crucial initiatives owe their existence to the unwavering generosity of our donors.” Catalyst Award informs recreational cannabis policy Lara Coughlin, Ph.D., assistant professor at the U-M Addiction Center, received the Catalyst Award for her work to inform cannabis policy and reduce harm through regulation of the legal cannabis market. Dr. Coughlin and her team developed a tool called the Experimental Cannabis Marketplace, a makebelieve online dispensary Lara Coughlin, Ph.D. that allows them to test out policies and understand how they will affect cannabis purchasing behaviors. The team can manipulate the fictional regulatory environment on the site. For example, they can study the effects of different taxes on higher-risk cannabis products. “We now know what we wish we had done to regulate tobacco
decades ago,” says Dr. Coughlin. “This will allow us to get ahead of the ball on regulation for cannabis to prevent cannabis-related harm to consumers.” Dr. Coughlin hopes that this research will help to prevent the development of cannabis use disorder by prospectively informing policies that will help reduce potential harms from legal cannabis. “The whole country is grappling with the rapid-fire legalization of cannabis use. We are hoping to create a policy environment that minimizes public health harms from cannabis use,” she says. Dr. Coughlin credits the Catalyst Award with making innovative research like this possible. “The real beauty of the Catalyst Award is that it provides the opportunity to study high-risk, high-reward work that might not yet be ready for federal funding,” she says. “The Catalyst Award enabled me to develop this web-based tool to understand how regulatory policies impact the choices consumers make before they’re enacted. This is so powerful, because often in the policy realm we do not have enough data to make the best decisions possible.” Dr. Coughlin and her team tested the Experimental Cannabis Marketplace site on 62 people who use and buy cannabis legally. Their paper, Development and Pilot Testing of an Experimental Cannabis Marketplace: Toward Evaluating the Impact of Cannabis Policy on Consumer Choices, was recently published in Cannabis and Cannabinoid Research. This strong foundation propelled her team to submit a grant application to the NIH in August of 2023. They have requested $2.5 million to test the prototype on a national sample of young adults. “This will help us estimate the impact of policies nationally,” says Dr. Coughlin. “We are most concerned with young adults because they are most likely to use high-risk, highpotency, and multiple cannabis products. We are concerned about the cannabis use patterns they are developing. There are ripe opportunities to leverage donor support to make a really meaningful impact. I am grateful for this opportunity through the Catalyst Award, and I am excited for what’s to come.”
9
FACULTY SUPPORT Professorships Honor Incredible Legacies Our faculty are critical to the success of our research, education, and patient care programs, and professorships are essential to our efforts to attract and retain these talented experts. Many endowed professorships are made possible by philanthropy and honor legacies by giving faculty a dependable foundation of support to carry on a commitment to a cause or an area of research. We are proud to introduce some of our newest professorships and the faculty who honor incredible legacies through their work to increase understanding of mental health and provide the best care possible to the people we serve.
Albert J. Silverman, M.D., C.M. Research Professorship in Psychiatric Disorders
LEFT: Dr. Dalack presenting Dr. Taylor with the professorship medallion during the installation of the professorship RIGHT: The Silvermans
Stephan Taylor, M.D., professor of psychiatry and associate chair for research and research regulatory affairs, was appointed the inaugural Albert J. Silverman, M.D., C.M. Research Professor of Psychiatric Disorders in 2022. This professorship was established by Dr. Silverman’s wife, Halina Silverman, to honor her late husband’s memory while enabling future leaders in the field to carry on his trailblazing legacy. Dr. Silverman, the department chair from 19701981, is remembered as an outstanding psychiatrist, researcher, psychoanalyst, and leader who spent his career working to bridge the gap between neurosciencebased psychiatry and traditional psychoanalysis.
Dr. Taylor is widely known for his neuromodulation and neuroimaging expertise and is carrying on his former teacher’s legacy through his work to use brain imaging, brain stimulation, and behavioral techniques to develop and improve treatments for psychiatric disorders. “If it is successful,” he says, “it will give us a new form of treatment for serious mental illness.” Dr. Taylor was named a fellow of the American Association for the Advancement of Science in 2021, one of the scientific community’s most distinguished honors. His dedication to improving the lives of people struggling with mental illness embodies the intent of the professorship and is an incredible tribute to the memory of Dr. Silverman.
Stanley Berent, Ph.D. Collegiate Professorship in Psychology*
Stanley Berent, Ph.D.
Benjamin Hampstead, Ph.D.
Benjamin Hampstead, Ph.D., professor of psychology and director of the Research Program on Cognition and Neuromodulation Based Interventions, was appointed the inaugural Stanley Berent, Ph.D. Collegiate Professor of Psychology in the Department of Psychiatry in 2021. This professorship honors the memory of Stanley Berent, Ph.D., who is remembered as a passionate and talented psychologist, clinician, researcher, and educator who made many contributions to his field. He was passionate about training the next generation of neuropsychologists and mentored many medical students, residents, graduate students, postdoctoral fellows, and junior faculty.
“Dr. Berent would be pleased to know that Dr. Benjamin Hampstead is being installed as the inaugural Berent Professor, as Dr. Hampstead shares his commitment to transformative research, outstanding training of the next generation of neuropsychologist clinician-scientists, and advancing clinical care through research endeavors,” says Gregory Dalack, M.D., Daniel E. Offutt, III Professor of Psychiatry and chair of the Department of Psychiatry. Dr. Hampstead focuses on the assessment and treatment of aging, dementia, and other neurological conditions, and he is especially interested in using non-pharmacological approaches to improve functioning. He is also an expert in non-invasive brain stimulation, and he and his research team use brain imaging to better understand why problems emerge and to measure the effects of brain stimulation interventions. *This professorship was established by the Provost and is funded by the Department of Psychiatry for a term of three years.
10
Marcia A. Valenstein, M.D. Collegiate Professorship in Psychiatry*
Drs. Marcia Valenstein and Kara Zivin
Kara Zivin, Ph.D., professor of psychiatry, was appointed the inaugural Marcia A. Valenstein, M.D. Collegiate Professor of Psychiatry in 2022. This professorship honors Marcia Valenstein, M.D., professor emerita of psychiatry at U-M and research scientist in the Department of Veterans Affairs. Dr. Valenstein followed a nontraditional career path, joining the Department of Psychiatry as a part-time clinician in 1989 and pursuing additional opportunities and training throughout her career to establish herself as a nationally-leading health services researcher. Dr. Valenstein’s research focused on assessing and improving the quality of mental health services, with an emphasis on improving care for depression.
Dr. Zivin met Dr. Valenstein when she was interviewing for her first faculty position at U-M. As Dr. Zivin began her career, Dr. Valenstein became her mentor because of their shared interest in health services research related to depression screening and treatment. Dr. Zivin’s own experience with and recovery from severe insomnia, depression, and anxiety during and after her pregnancy led her to shift her research focus to health care access for women with mental health and substance use conditions during and after pregnancy. Like Dr. Valenstein, Dr. Zivin continues to pursue new training opportunities and received a Master of Fine Arts degree in creative nonfiction writing in 2021 so she could better share her experiences with people outside of medical research. *This professorship was established by the Provost and is funded by the Department of Psychiatry for a term of three years.
The Michelle B. Riba, M.D., Endowment in Psychiatry A cancer patient’s psychological condition and understanding of the emotional aspects of cancer can have an important impact on their mental and physical well-being. The PsychOncology Program in the Rogel Cancer Center helps patients and their families navigate the mental and emotional complexities of cancer from diagnosis through treatment, and beyond. Michelle Riba, M.D., professor of psychiatry, was instrumental in creating the PsychOncology Program and now serves as its director. Her work with cancer patients, patients with other serious medical illnesses, and their families has made an invaluable difference to the field of psychiatry, and in the lives of countless Michigan Medicine patients and their loved ones. Thanks to the support of so many people whose lives have been touched by Dr. Riba, an endowment has been established in her name to honor her many contributions and accomplishments in patient care, research, and mentorship. Funds will be used to support leadership in psychoncology and to engage early career researchers and clinicians in the field — an important contribution to the next generation of experts. This endowment will be a lasting and meaningful way to carry on Dr. Riba’s commitment to helping patients and families who face serious medical diagnoses.
“The distress is most difficult at diagnosis and after treatment is complete, when the person re-enters their normal routine. Understanding the emotional aspects of cancer can alleviate stigma and guilt. Many patients are relieved to find out that it is common, that they didn’t cause it, and that it can be treated. If we don’t provide this information to patients, they often fail to alert us to their symptoms.” - Dr. Riba
11
NON PROFIT ORG US POSTAGE PAID PERMIT #144 ANN ARBOR, MI
Department of Psychiatry F6327, University Hospital South 1500 E. Medical Center Dr, SPC 5295 Ann Arbor, MI 48109-5295
WITH GRATITUDE Thank you for your support of the important work of the University of Michigan Health Department of Psychiatry. You are helping us to find new ways to understand brain illnesses and to improve lives through the pursuit of promising new interventions aimed at prevention, reducing the recurrence of symptoms, building resilience, and maintaining wellness. We are so grateful for your partnership.
To learn more, please contact the Michigan Medicine Mental Health Development Team at teammentalhealth@umich.edu.
Executive Officers of Michigan Medicine: Marschall S. Runge, M.D., Ph.D., Executive Vice President for Medical Affairs, Dean, University of Michigan Medical School, CEO, Michigan Medicine; Steven L. Kunkel, Ph.D., Executive Vice Dean for Research, Medical School; David C. Miller, M.D., MPH, Executive Vice Dean for Clinical Affairs, Medical School, President, University of Michigan Health; Debra F. Weinstein, M.D., Executive Vice Dean for Academic Affairs, Medical School.
Regents of the University of Michigan: Jordan B. Acker, Michael J. Behm, Mark J. Bernstein, Paul W. Brown, Sarah Hubbard, Denise Ilitch, Ron Weiser, Katherine E. White, Santa J. Ono (ex officio). A Non-discriminatory, Affirmative Action Employer © 2023 Regents of the University of Michigan